CXCL16 and breast carcinoma: The upregulation of CCR1 and CXCR6 and the downregulation of CXCR6 ligand (CXCL16) in cells other than MB-231, suggest that alternative chemokine-related axes may be involved in the trafficking of breast cancer cells to the bone marrow.